BUSINESS● LOWJul 20 · Jul 20, 2026, 2:12 AM
Samsung Biologics to acquire Switzerland's PolyPeptide Group in $1.8 billion all-cash deal
CNBC
South Korea's Samsung Biologics said on Monday that it had made an all-cash bid of 1.46 billion Swiss francs ($1.8 billion) for Switzerland's PolyPeptide Group.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Business
BUSINESSnowMunicipal Securities Underwriters Pay a Total of $325,000 in FinesSECBUSINESSnowSEC CHAIRMAN ARTHUR LEVITT, IOWA OFFICIALS TO HOLD INVESTORS’ TOWN MEETING IN DES MOINESSECBUSINESS29m agoFAAN’s Vision for the Airport of the Future: Technology, infrastructure and passenger-centric innovationVanguard NigeriaBUSINESS32m agoSoutheast Asia’s EV boom sidelines local car parts suppliersSouth China Morning Post